FDA seeks public comment on proposed information collection for allegations of regulatory misconduct submitted to CDRH

This notice allows stakeholders to comment on FDA's plan to collect and manage voluntary reports of regulatory misconduct involving medical devices and radiological health products. The Food and Drug Administration (FDA) has published a notice in the Federal Register announcing a 60-day public...